Probing stereoselective inhibition of the acyl binding site of cholesterol esterase with four diastereomers of 2′-N-α-methylbenzylcarbamyl-1, 1′-bi-2-naphthol

BMC Biochemistry

Volumn 6, Issue , 2005, Pages

  Chiou, Shyh Ying ^a   Lai, Cheng Yue ^b   Lin, Long Yau ^a   Lin, Gialih ^c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

2' N ALPHA METHYLBENZYLCARBAMYL 1,1' BI 2 NAPHTHOL; CHOLESTEROL ESTERASE; NAPHTHOL DERIVATIVE; PYRIDINE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BINDING SITE; CARBAMOYLATION; CATALYSIS; CATALYST; DIASTEREOISOMER; ENZYME SUBSTRATE; ENZYME SYNTHESIS; MOLECULAR PROBE; POLYMERIZATION; STEREOCHEMISTRY;

ANIMALS; BINDING SITES; CHOLESTEROL, DIETARY; CRYSTALLOGRAPHY, X-RAY; ENZYME INHIBITORS; KINETICS; NAPHTHOLS; STEREOISOMERISM; STEROL ESTERASE; TORPEDO;

EID: 26844461451     PISSN: 14712091     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-6-17     Document Type: Article

References (40)

1. Hui DY: Molecular biology of enzymes involved with cholesterol esterase hydrolysis in mammalian tissues. Biochim Biophys Acta 1996, 1303:1-14.
2. Lopez-Candales A, Bosner MS, Spilburg CA, Lange LG: Cholesterol transport function of pancreatic cholesterol esterase: directed sterol uptake and esterification in Enterocytes. Biochemistry 1993, 32:12085-12089.
3. Brockerhoff H, Jensen RG: Cholesterol esterase. In Lipolytic Enzymes New York: Academic Press; 1974.
4. Wang C-S, Hartsuck JA: Bile salt-activated lipase. A multiple function lipolytic enzymes. Biochim Biophys Acta 1993, 1166:1-19.
5. Quinn DM, Sutton LD, Stout JS, Calogeropoulou T, Wiemer DF: Phospholipase A2 activity and catalytic mechanism of pancreatic cholesterol esterase. Phosphorus Sulfur Silicon 1990, 51/52:43-46.
6. Howles PN, Carter CP, Hui DY: Dietary free and esterified cholesterol absorption in cholesterol esterase (bile salt-stimulated lipase) gene-targeted mice. Biol Chem 1996, 271:7196-7202.
7. Miura S, Chiba T, Mochizuki N, Nagura H, Nemoto K, Tomita I, Ikeda M, Tomita T: Cholesterol-mediated changes of neutral cholesterol esterase activity in macrophages. Mechanism for mobilization of cholesterol esteryl esters in lipid droplets by HDL. Arterioscler Thromb Vasc Biol 1997, 17:3033-3040.
8. Brodt-Eppley J, White P, Jenkins S, Hui DY: Plasma cholesterol esterase level is a determinant for an atherogenic lipoprotein profile in normolipidemic human subjects. Biochim Biophys Acta 1995, 1272:69-72.
9. Cygler M, Schrag JD, Sussman JL, Harel M, Silman I, Gentry MK, Doctor BP: Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases, and related proteins. Protein Sci 1993, 2:366-382.
10. Ollis DL, Cheah E, Cygler M, Dijkstra B, Frolow F, Franken SM, Harel M, Remington SJ, Silman I, Schrag JD, Sussman JL, Vershueren KHG, Goldman A: The α/β hydrolase fold. Protein Eng 1992, 5:197-211.
11. Svendsen A: Sequence comparison with the lipase family. In Lipases, Their Structure Biochemistry and Application Edited by: Woolley P, Petersen SB. Cambridge :Cambridge University Press; 1994:1-21.
12. Svendsen A: Lipase protein engineering. Biochim Biophys Acta 2000, 1543:223-238.
13. Doorn JA, Talley TT, Thompson CM, Richardson RJ: Probing the active sites of butyrylcholinesterase and cholesterol esterase with isomalathion: conserved Stereoselective inactivation of serine hydrolases structurally related to acetylcholinesterase. Chem Res Toxicol 2001, 14:807-813.
14. Deck LM, Baca ML, Salas SL, Hunsaker LA, Vander Jagt DL: 3-Alkyl-6-chloro-2-pyrones: selective inhibitors of pancreatic cholesterol esterase. J Med Chem 1999, 42:4250-4256.
15. Sohl J, Sutton LD, Burton DJ, Quinn DM: Haloketone transition state analog inhibitors of cholesterol esterase. Biochim Biophys Res Comm 1988, 151:554-560.
16. Feaster SR, Quinn DM: Mechanism-based inhibitors of mammalian cholesterol esterase. Methods Enzymol 1997, 286:231-252.
17. Hosie L, Sutton LD, Quinn DM: p-Nitrophenyl and cholesteryl-N-alkyl carbamates as inhibitors of cholesterol esterase. J Biol Chem 1987, 262:260-264.
18. Feaster SR, Lee K, Baker N, Hui DY, Quinn DM: Molecular recognition by cholesterol esterase of active site ligands: structure-reactivity effects for inhibition by aryl carbamates and subsequent carbamylenzyme turnover. Biochemistry 1996, 35:16723-16734.
19. Lin G, Lai C-Y: Hammett analysis of the inhibition of pancreatic cholesterol esterase by substituted phenyl-N-butylcarbamate. Tetrahedron Lett 1995, 36:6117-6120.
20. Lin G, Liu H-C, Tsai Y-C: Atropisomeric carbamoyl type inhibitors of pancreatic cholesterol esterase. Bioorg Med Chem Lett 1996, 6:43-46.
21. Lin G, Lai C-Y: Linear free energy relationships of the inhibition of pancreatic cholesterol esterase by 4-nitrophenyl-N-alkylcarbamate. Tetrahedron Lett 1996, 37:193-196.
22. Lin G, Tsai Y-C, Liu H-C, Liao W-C, Chang C-H: Enantiomeric inhibitors of cholesterol esterase and acetylcholinesterase. Biochim Biophys Acta 1998, 1388:161-174.
23. Lin G, Shieh C-T, Tsai Y-C, Hwang C-I, Lu C-P: Structure-reactivity probes for active site shapes of cholesterol esterase by carbamate inhibitors. Biochim Biophys Acta 1999, 1431:500-511.
24. Lin G, Shieh C-T, Ho H-C, Chouhwang J-Y, Lin W-Y, Lu C-P: Structure-reactivity relationships for the inhibition mechanism at the second alkyl chain binding site of cholesterol esterase and lipase. Biochemistry 1999, 38:9971-9981.
25. Lin G, Lai C-Y, Liao W-C, Kao B-H, Lu C-P: Structure-reactivity relationships as probes for the inhibition mechanism of cholesterol esterase by aryl carbamates. I. Steady-state kinetics. J Chin Chem Soc 2000, 47:489-500.
26. Lin G: The Hammett-Taft cross-interactions for the inhibition mechanism of cholesterol esterase by substituted phenyl-N-substituted carbamates. J Phys Org Chem 2000, 13:313-321.
27. Lin G, Liao W-C, Chiou S-Y: Quantitative structure-activity relationships for the pre-steady-state inhibition of cholesterol esterase by 4-nitrophenyl-N-substituted carbamates. Bioorg Med Chem 2000, 8:2601-2607.
28. Lin G, Liu Y-C, Wu Y-G: Ortho effects and cross interaction correlations for the mechanism of cholesterol esterase inhibition by aryl carbamates. J Phys Org Chem 2004, 17:707-714.
29. Lin G, Lee Y-R, Liu Y-C, Wu Y-G: Ortho effects for inhibition mechanisms of butyrylcholinesterase by o-substituted phenyl N-butylcarbamates and comparison with acetylcholinesterase, cholesterol esterase, and lipase. Chem Res Toxicol 2005 in press.
30. Wang X, Wang C-S, Tang J, Dyda F, Zhang XC: The crystal structure of bovine bile salt activated lipase: insights into the bile salt activation mechanism. Structure 1997, 5:1209-1218.
31. Chen JC-H, Miercke LJW, Krucinski J, Starr JR, Saenz G, Wang X, Spilburg CA, Lange LG, Ellsworth JL, Stroud RM: Structure of bovine pancreatic cholesterol esterase at 1.6Å: novel structural features involved in lipase activation. Biochemistry 1998, 37:5107-5117.
32. Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I: Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 1991, 253:872-879.
33. Grochulski P, Li Y, Schrag JD, Bouthillier F, Bouthillier F, Smith P, Harrison D, Rubin B, Cygler M: Insights into interfacial activation from an 'open' structure of Candida rugosa lipase. J Biol Chem 1993, 268:12843-12847.
34. Grochulski P, Bouthillier F, Kazlauskas RJ, Serreqi AN, Schrag JD, Ziomek E, Cygler M: Analogs of reaction intermediates identify a unique substrate binding site in Candida rugosa lipase. Biochemistry 1994, 33:3494-3500.
35. Schrag JD, Li Y, Cygler M: 1.8Å refined structure of the lipase from Geotrichum candidum. J Mol Biol 1993, 230:575-591.
36. Schrag JD, Li Y, Cygler M, Lang D, Burgdorf T, Hecht H-J, Schmid R, Schomburg D, Rydel TJ, Oliver JD, Strickland LC, Dunaway M, Larson SB, Day J, McPherson A: The Open Conformation of a Pseudomonas Lipase. Structure 1997, 5:187-202.
37. Lang DA, Mannesse MLM, De Haas GH, Verheij HM, Dijkstra BW: Structure Basis of the Chiral Selectivity of Pseudomonas cepacia Lipase. Eur J Biochem 1998, 254:333-340.
38. Abeles RH, Maycock AL: Suicide enzyme inactivators. Acc Chem Res 1976, 9:313-319.
39. Berglund P, Holmquist M, Hult K: Reversed enantiopreference of Candida rugosa lipase supports different modes of binding enantiomers of a chiral acyl donor. J Mol Cat B Enzym 1998, 5:283-287.
40. Stadler P, Zandonella G, Haalck L, Spener F, Hermetter A, Paltauf F: Inhibition of microbial lipases with stereoisomeric triglycerol analog phosphonates. Biochim Biophys Acta 1996, 1304:229-244.